Furthermore, other mutations, including MEK1(P124L) and MEK1(Q56P), located near the N-terminal regulatory helix induced cross-resistance to the BRAFi PLX4720 in melanoma [116]. The gene discussed is MAP2K1; the disease is melanoma.